|
🐜
|
Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
34 auth.
A. Heravi‐Moussavi,
M. Anglesio,
S. G. Cheng,
J. Senz,
Winnie Yang,
Leah M Prentice,
Anthony P. Fejes,
C. Chow,
A. Tone,
S. Kalloger,
N. Hamel,
Andrew Roth,
G. Ha,
A. Wan,
S. Maines-Bandiera,
...
C. Salamanca,
B. Pasini,
B. Clarke,
Anna F. Lee,
Cheng-Han Lee,
Chengquan Zhao,
R. Young,
Samuel Aparicio,
P. Sorensen,
M. Woo,
Niki Boyd,
Steven J. M. Jones,
M. Hirst,
M. Marra,
B. Gilks,
Sohrab P. Shah,
W. Foulkes,
G. Morin,
D. Huntsman
|
8 |
2012 |
8
🐜
|
|
🐜
|
Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research
14 auth.
M. Anglesio,
Kimberly C. Wiegand,
Nataliya Melnyk,
C. Chow,
C. Salamanca,
Leah M Prentice,
J. Senz,
Winnie Yang,
M. Spillman,
D. Cochrane,
...
K. Shumansky,
Sohrab P. Shah,
S. Kalloger,
D. Huntsman
|
7 |
2013 |
7
🐜
|
|
🐜
|
Cancer‐associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse‐strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage
10 auth.
Anglesio,
Yi Kan Wang,
Winnie Yang,
J. Senz,
Adrian Wan,
Alireza Heravi-Moussavi,
...
C. Salamanca,
S. Maines-Bandiera,
D. Huntsman,
Gregg B. Morin
|
7 |
2013 |
7
🐜
|
|
🐜
|
The Specificity of the FOXL2 c.402C>G Somatic Mutation: A Survey of Solid Tumors
15 auth.
K. Schrader,
Bella O. Gorbatcheva,
J. Senz,
A. Heravi‐Moussavi,
Nataliya Melnyk,
C. Salamanca,
S. Maines-Bandiera,
S. Cooke,
P. Leung,
J. Brenton,
...
C. Gilks,
J. Monahan,
D. Huntsman,
D. Huntsman,
D. Huntsman
|
6 |
2009 |
6
🐜
|
|
🐜
|
Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers
34 auth.
K. Schrader,
S. Masciari,
Niki Boyd,
C. Salamanca,
J. Senz,
D. N. Saunders,
E. Yorida,
S. Maines-Bandiera,
P. Kaurah,
Nadine Tung,
Mark E Robson,
Paula D. Ryan,
O. Olopade,
S. Domchek,
James M. Ford,
...
Claudine Isaacs,
Powel H. Brown,
Judith Balmaña,
Abdul Rab Razzak,
P. Miron,
K. Coffey,
M. Terry,
Esther M. John,
Esther M. John,
I. Andrulis,
J. Knight,
Frances P. O'Malley,
M. Daly,
P. Bender,
R. Moore,
M. Southey,
John L. Hopper,
Judy Garber,
D. Huntsman
|
6 |
2010 |
6
🐜
|
|
🐜
|
Clear cell and endometrioid carcinomas: are their differences attributable to distinct cells of origin?
11 auth.
D. Cochrane,
B. Tessier-Cloutier,
Katherine M Lawrence,
T. Nazeran,
A. Karnezis,
C. Salamanca,
...
A. Cheng,
J. McAlpine,
L. Hoang,
C. Gilks,
D. Huntsman
|
6 |
2017 |
6
🐜
|
|
🦁
|
Effects of Epidermal Growth Factor/Hydrocortisone on the Growth and Differentiation of Human Ovarian Surface Epithelium
C. Salamanca,
S. Maines-Bandiera,
P. Leung,
Yu-long Hu,
N. Auersperg
|
5 |
2004 |
5
🦁
|
|
🐬
|
An improved assay to quantitate the invasiveness of cells in modified Boyden chambers
M. Woo,
C. Salamanca,
A. Minor,
N. Auersperg
|
5 |
2007 |
5
🐬
|
|
🐬
|
αvβ3 and Vitronectin Expression by Normal Ovarian Surface Epithelial Cells: Role in Cell Adhesion and Cell Proliferation
S. Cruet,
C. Salamanca,
G. Mitchell,
N. Auersperg
|
5 |
1999 |
5
🐬
|
|
🐜
|
Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target
15 auth.
Marta Llauradó Fernández,
A. Dawson,
J. Hoenisch,
Hannah Kim,
Sylvia Bamford,
C. Salamanca,
G. DiMattia,
T. Shepherd,
M. Cremona,
B. Hennessy,
...
Shawn Anderson,
S. Volik,
C. Collins,
D. Huntsman,
M. Carey
|
5 |
2019 |
5
🐜
|
